Mimedx Group, Inc · NASDAQ:MDXG

Mimedx — Investor Presentation (June 2026)

25 slides from Mimedx's investor presentation, June 2026

  1. Slide 1: Biomimetic Matrix Product Overview

    ® Biomimetic Matrix PRODUCT OVERVIEW 1 | US-GD-2600005 v2.0 Distributed By

  2. Slide 2: Outline

    Outline • Clinical Challenges of Complex • Product #, Sizes, & Wound Area Wounds Coverage • What is a Self-Assembling Peptide? • Application Guide • Product Introduction and Indications • Package Contents, Shelf Life, and for Use Storage • Key Benefits & Versatility for • Cautions and Contraindicati

  3. Slide 3: The Stages of Healing Are Similar Throughout the Body

    The Stages of Healing Are Similar Throughout the Body 3 | US-GD-2600005 v2.0 Distributed By

  4. Slide 4: There Are Risk Factors that Impair Healing and/or Delay Wound Closure

    There Are Risk Factors that Impair Healing and/or Delay Wound Closure1 Patient Defect/Wound Timing • Diabetes • Contamination or infection • Slow healing • Older age • Exposed tendon or bone • Chronic wound • Obesity • Recurrence • Not yet candidate for • Smoking • Irradiated tissue definitive closu

  5. Slide 5: What Is a Self-Assembling Peptide (SAP)?

    What Is a Self-Assembling Peptide (SAP)? • Short peptides made of essential amino acids • Synthetically manufactured • Supportive 3D scaffold that mimics the native Extracelluar Matrix (ECM) • Designed to support cell infiltration, revascularization, and tissue repair • Matrix can act as a barrier a

  6. Slide 6: What Is G4Derm Plus?

    What Is G4Derm® Plus? G4Derm Plus is an acellular flowable Extracellular Matrix (ECM) designed to optimally manage complex wounds. It supports healing and serves as an antibacterial barrier to protect the wound bed from external contamination.1 G4Derm Plus utilizes self-assembling peptide technology

  7. Slide 7: G4Derm Plus in Complex Wounds

    G4Derm Plus in Complex Wounds Designed to Support Host Tissue Repair2,3 & Antibacterial Protection4 Flowable matrix enters the wound, Cells begin infiltrating the scaffold The matrix serves as an antibacterial conforms to the wound surface and and attach to the peptide-based barrier, protecting the

  8. Slide 8: G4Derm Plus Serves as a Scaffold for Cellular Infiltration and Capillary Ingrowth

    G4Derm Plus Serves as a Scaffold for Cellular Infiltration and Capillary Ingrowth1 G4Derm Plus mimics the microarchitecture of G4Derm Plus supported revascularization in vivo. the native ECM. Immunohistochemistry staining of CD31 (blood vessels) Scanning Electron Microscopy (SEM) magnification in wo

  9. Slide 9: G4Derm Plus Antibacterial Barrier

    G4Derm Plus Antibacterial Barrier1 G4Derm Plus Forms a Barrier to External Bacterial Contamination of the Wound Surface ANTIBACTERIAL BARRIER In vitro study demonstrated that G4Derm Plus served as an effective antibacterial barrier for up to 7 days against: • Gram-positive bacteria* • Gram-negative

  10. Slide 10: Indications for Use

    Indications for Use G4Derm Plus may be used under the supervision of health care professionals for the local management of partial- and full-thickness wounds including: • Surgical wounds • Lower extremity ulcers including venous, arterial, • Pressure ulcers and mixed etiology • Diabetic ulcers • Fir

  11. Slide 11: Key Benefits

    Key Benefits • Biomimetic matrix • Allows for maximal wound bed that supports:1,2 contouring and filling soft • Revascularization tissue voids3 • Granulation tissue formation • Serves as a durable antibacterial barrier4,5 • Re-epithelization • Ready-to-use pre-filled Syringe • Up to 3-year shelf lif

  12. Slide 12: Versatile for Wounds

    Versatile for Wounds Application Considerations Biomimetic Matrix  Serves as a Durable Antibacterial Barrier1,2  Wound Area Coverage (2 mL ≈ 25 cm2)  Flexible Applicator Tip May Reach Deeper Wounds (Applicator Tip Length: ~ 12.5 cm)  Coating Thickness of Flowable Matrix (~ 1 mm)  Ready to Use a

  13. Slide 13: Suitable for Wounds Across Diverse Surgical Specialties

    Suitable for Wounds Across Diverse Surgical Specialties POTENTIAL EXAMPLES • Plastic Reconstruction • Foot and Ankle • Trauma • General • Vascular • Orthopedic • Spine • Burns 13 | US-GD-2600005 v2.0 Distributed By

  14. Slide 14: Product Size, Storage, Shelf Life, & GTIN #

    Product Size, Storage, Shelf Life, & GTIN # STORAGE SHELF LIFE • Store at +2°C to +30°C • Up to 3 Years (+36°F to +86°F) • Do not freeze • Avoid excessive heat • Keep dry G4Derm Plus 2 mL Syringe and Applicator Tip/Nozzle (Applicator Tip/Nozzle Length: ~ 12.5 cm) Syringe ~ Wound Area ~ Coating Produ

  15. Slide 15: Application Guide

    Application Guide1 Before Use: Read Instructions for Use. G4Derm Plus is intended for use in adults 18 years of age or older. Confirm there is no damage to pouches, Syringe, or flexible Applicator Tip. Do not use the product if damaged or leaks are noted. Do not use the product if the Syringe top ca

  16. Slide 16: Application Guide (cont.)

    Application Guide (cont.)1 3. Remove Top Cap 3. Hold the Syringe and remove the top cap. 4. Prime Syringe • Optional: If using the flexible Applicator Tip for application, connect the flexible Applicator Tip by securely attaching it to the syringe head. 4. Prior to G4Derm Plus application, prime the

  17. Slide 17: Application Guide (cont.)

    Application Guide (cont.)1 5. Dispense G4Derm Plus directly onto the wound by gently pressing the plunger rod. Apply enough product to coat the wound bed. Fill any void spaces. • Precaution: The recommended maximum patient exposure of G4Derm Plus is 10 g/day • 10g of G4Derm Plus = 5 units of 2 mL^ 6

  18. Slide 18: Product Handling & Application Considerations

    Product Handling & Application Considerations • G4Derm Plus is a flowable biomimetic wound matrix intended to facilitate controlled handling and application. • When applied continuously or intermittently, the product moves smoothly from the syringe with or without the flexible Applicator Tip. G4Derm

  19. Slide 19: Product Is Provided Sterile Packaged for Single Use Only

    Product Is Provided Sterile Packaged for Single Use Only Box Includes: • One sterile single-use pre-filled G4Med Plus Syringe (2 mL) • One sterile single-use flexible Applicator Tip • Instructions for Use (IFU) • 6 patient labels Shelf Life and Storage: • Up to 3-year shelf life • Store at +2°C to +

  20. Slide 20: Precautions

    Precautions • Keep out of the reach of children. • Not for injection. • The recommended maximum patient exposure of G4Derm Plus is 10 g/day. • G4Derm Plus is a sterile product. Do not re-sterilize. • Product is guaranteed to be sterile and nonpyrogenic unless the package is opened or damaged. • Do n

  21. Slide 21: Contraindications

    Contraindications1 Do not use G4Derm Plus on patients with a known sensitivity / previous allergic reaction to the product or any of its components. No contraindications related to contaminated wounds* 1. G4Med, Inc. G4Derm Plus: Instructions for Use. Document No. PL-0001 Rev 3.0. Brighton, MA. * Th

  22. Slide 22: Biomimetic Matrix Regulatory Clearance

    Biomimetic Matrix Regulatory Clearance 22 | US-GD-2600005 v2.0 Distributed By

  23. Slide 23: 510(k) Regulatory Clearance

    510(k) Regulatory Clearance • G4Derm Plus was 510(k) cleared in 2023 as a medical device. • Manufacturer: Gel4Med, Inc. U.S. Food and Drug Administration. 510(k) Premarket notification clearance letter: G4Derm / G4Derm Plus Synthetic Wound Matrix. 510(k) No. K222025. Silver Spring, MD, Center for De

  24. Slide 24: Indication for Use

    Indication for Use: G4Derm Plus may be used under the supervision of health care professionals for the local management of partial-and full-thickness wounds including pressure, and diabetic ulcers; lower extremity ulcers including those of venous, arterial and mixed etiology; surgical wounds; first-

  25. Slide 25: Biomimetic Matrix

    Biomimetic Matrix LEARN MORE ABOUT MIMEDX PRODUCTS 866.477.4219 customerservice@mimedx.com G4Derm Plus is owned and manufactured by Gel4Med Inc. and distributed by MIMEDX Group, Inc. MIMEDX is a trademark of MIMEDX Group, Inc. All other trademarks are owned by their respective owners. ©2026 MIMEDX G

MiMedx Group — Investor Presentation (June 2026) on 6ix